DOI QR코드

DOI QR Code

항생제 치료에도 반복되는 기관지확장증 환자의 기관지폐렴에 대한 한양방 복합 치험 1례

Recurrent Bronchopneumonia in Bronchiectasis, Despite Antibiotic Treatment: A Case Report on Combined Treatment with Korean and Western Medicine

  • 신정원 (경희대학교 한방병원 폐장호흡내과) ;
  • 박지원 (경희대학교 대학원 임상한의학과 폐계내과학교실) ;
  • 진수현 (경희대학교 한방병원 폐장호흡내과) ;
  • 정희재 (경희대학교 한방병원 폐장호흡내과) ;
  • 김관일 (경희대학교 한방병원 폐장호흡내과) ;
  • 이범준 (경희대학교 한방병원 폐장호흡내과)
  • Jeong-Won Shin (Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee Korean Medicine Hospital) ;
  • Jiwon Park (Division of Allergy, Immune & Respiratory System, Dept. of Internal Medicine, Graduate School, Kyung Hee University) ;
  • Su-Hyun Chin (Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee Korean Medicine Hospital) ;
  • Hee-Jae Jung (Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee Korean Medicine Hospital) ;
  • Kwan-Il Kim (Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee Korean Medicine Hospital) ;
  • Beom-Joon Lee (Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee Korean Medicine Hospital)
  • 투고 : 2024.04.28
  • 심사 : 2024.05.29
  • 발행 : 2024.05.30

초록

Background: Bronchiectasis is a chronic respiratory condition leading to recurrent respiratory infections. Despite the use of antibiotics and other standard treatments, managing bronchiectasis remains challenging due to the frequent recurrence of airway infections and concerns about antimicrobial resistance. Given these challenges, traditional Korean medicine (TKM) has gained attention due to its potential to reduce the frequency of respiratory infections, possibly minimizing the need for antibiotics. Case report: A 59-year-old female with bronchiectasis experienced recurrent pneumonia and was treated with antibiotics for over 2 weeks without any significant improvement in clinical symptoms. She received comprehensive Korean medicine treatment, including herbal medicine (Sikyungbanha-tang combined with Bigwabojungikki-tang-gami), acupuncture, and Chuna manual therapy, for pulmonary rehabilitation. Post-treatment, clinically meaningful improvements were observed in symptoms, serum C-reactive protein (CRP) levels, and bronchopneumonic lesions on chest X-rays. Conclusion: This case suggests that complex traditional Korean medicine treatments for recurrent chronic airway inflammation due to bronchiectasis can lead to clinically significant improvements in symptoms and help to prevent recurrence.

키워드

과제정보

이 논문은 2024년도 한국보건산업진흥원 한의기반융합기술개발사업의 다빈도 난치성 천식 협진치료(No. HI20C120501)의 지원을 받아 수행된 과제입니다.

참고문헌

  1. O'Donnell AE. Bronchiectasis update. Curr Opin Infect Dis 2018;31(2):194-8.
  2. Seo HW, Cha SI, Park JM, Lim JK, Lee WK, Park JE, et al. Clinical relevance of bronchiectasis in patients with community-acquired pneumonia. Am J Med Sci 2023;365(6):502-9.
  3. Modi AR, Kovacs CS. Community-acquired pneumonia: Strategies for triage and treatment. Cleve Clin J Med 2020;87(3):145-51.
  4. Sfeir MM. Diagnosis of Multidrug-Resistant Pathogens of Pneumonia. Diagnostics (Basel) 2021;11(12):2287.
  5. Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et. al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017;50(3):1700629.
  6. Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med 2018;6(9):715-26.
  7. 전국한의과대학폐계내과학교실. 폐계내과학 (수정판). 원주: 의방출판사; 2024, p. 356-7.
  8. Lee H, Oh YM. Clinical approach to non-cystic fibrosis bronchiectasis based on recent clinical guideline. Korean J Med 2020;95(3):141-50.
  9. 전국한의과대학 공동교재편찬위원회. 本草學. 서울: 영림사; 2016.
  10. Park J, Kwon M, Lee BJ, Kim KI, Jung HJ. The Effectiveness and Safety of Chuna Manual Therapy Adjuvant to Western Medicine in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Single-Blind, Investigator-Initiated, Pilot Trial. Healthcare (Basel) 2024;12(2):152.
  11. Spinou A, Birring SS. An update on measurement and monitoring of cough: what are the important study endpoints? J Thorac Dis 2014;6(Suppl 7):S728-S734.
  12. Yun YH, Wang XS, Lee JS, Roh JW, Lee CG, Lee WS, et al. Validation study of the Korean version of the brief fatigue inventory. J Pain Symptom Manage 2005;29(2):165-72.
  13. Kim JW, Lee MY. Validity Evidences of VAS Pain Scale Utilizing Objective Physical Activity Measures in Middle-Aged Females with Low-Back Pain. The Korean Journal of Measurement and Evaluation in Physical Education and Sport Science 2013;15(2):29-39.
  14. Karakioulaki M, Stolz D. Biomarkers in Pneumonia-Beyond Procalcitonin. Int J Mol Sci 2019;20(8):2004.
  15. Polverino Eva, Cilloniz C, Menendez R, Gabarrus A, Rosales-Mayor E, Alcaraz V, et al. Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients. Journal of Infection 2015;71(1):28-36.
  16. Ramzi, N., Jamee, M. Bakhtiyari M, Rafiemanesh H, Zainaldain H, Tavakol M, et al. Bronchiectasis in common variable immunodeficiency: a systematic review and meta-analysis. Pediatric Pulmonology 2020;55(2):292-9.
  17. Cui J, Xu F, Tang Z, Wang W, Hu LL, Yan C, et al. Bu-Shen-Yi-Qi formula ameliorates airway remodeling in murine chronic asthma by modulating airway inflammation and oxidative stress in the lung. Biomedicine & Pharmacotherapy 2019;112:108694.
  18. Oshikiri T, Takiguchi G, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, et al. Postoperative recurrent laryngeal nerve palsy is associated with pneumonia in minimally invasive esophagectomy for esophageal cancer. Surg Endosc 2021;35(2):837-44.
  19. Asaka S, Shimakawa T, Yamaguchi K, Katsube T, Usui T, Yokomizo H, et al. Postoperative Pneumonia After Esophagectomy and Systemic Inflammatory Response Syndrome. Anticancer Res 2019;39(2):979-85.
  20. Lee SE, Shin JY, Lee SH. Shigyungbanha-tang Exhibits Anti-inflammatory Effects by Inhibiting IκB-α Degradation in LPS-stimulated Peritoneal Macrophages. J Int Korean Med 2007;28(3):442-52.
  21. Kim KT, Ko H. Effects of Shigyungbanha-Tang on the Lipopolysaccharide-Induced Acute Lung Injury in Mice. Journal of Physiology & Pathology in Korean Medicine 2009;23(6):1349-57.
  22. Park SR, Kim KH, Kwun MJ, Lee JY, Won R, Han CW, et al. Differential Regulation of NF-κB and Nrf2 by Bojungikki-Tang Is Associated with Suppressing Lung Inflammation. Evid Based Complement Alternat Med 2018;2018:5059469.
  23. Chun J, Park SM, Yi JM, Ha IJ, Kang HN, Jeong MK. Bojungikki-Tang Improves Response to PD-L1 Immunotherapy by Regulating the Tumor Microenvironment in MC38 Tumor-Bearing Mice. Front Pharmacol 2022;13:901563.
  24. Kim Y, Yang SY, Oh YS, Lee JW, Lee YK, Park YC. Research trends of Lonicera japonica over the last 10 years. Journal of Haehwa Medicine 2010;19(1):17-23.
  25. Ranneh Y, Mahmoud AM, Fadel A, Albujja M, Akim AM, Hamid HA, et al. Acute Inflammation and Oxidative Stress Induced by Lipopolysaccharide and the Ameliorative Effect of Stingless Bee Honey. Comb Chem High Throughput Screen 2021;24(6):744-57.
  26. Kong M, Lee SH, Kim J, Lee BJ, Kim KI. The Efficacy and Safety of Acupuncture for Preventing Radiation Pneumonitis in Patients With Lung Cancer: A Prospective, Single-Blinded, Randomized Pilot Proof-of-Principle Study. Integr Cancer Ther 2020;19:1534735420908327.
  27. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y, Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane database of systematic reviews 2015;2015(2):CD003793.
  28. Lyu YR, Park SJ, Lee EJ, Jung IC, Park YC. Application of Taesikbub and Lung-doyinbub in 「Dong-Ui-Bo-Gam」 as a Korean Traditional Pulmonary Rehabilitation Exercise. J Korean Med 2018;39(3):41-50.
  29. Kim TH, Lee SW, Lyu YR, Lee EJ, Jung IC, Park YC. Chronic Obstructive Pulmonary Disease Patients Treated with Korean Medicine Pulmonary Rehabilitation: Two case reports. J Korean Med 2020;41(3):162-72.